|
Post by gwb on Oct 9, 2014 16:16:37 GMT -5
|
|
|
Post by babaoriley on Oct 9, 2014 16:26:30 GMT -5
Spiro, check it out, there's your gal-pal, Leona, front and center!!
|
|
|
Post by joeypotsandpans on Oct 9, 2014 16:42:29 GMT -5
G, bet you would have liked some the last couple of weeks ....nice find
|
|
|
Post by spiro on Oct 14, 2014 11:58:13 GMT -5
No doubt that Technosphere and pain could become a huge product some day. But of course, when that happens the market will think it is bad news and MNKD will say nothing again.
|
|
|
Post by cybergym66 on Oct 14, 2014 12:11:56 GMT -5
No doubt that Technosphere and pain could become a huge product some day. But of course, when that happens the market will think it is bad news and MNKD will say nothing again. Stop that! You're sounding like me! I think MNKD should sell Technosphere to Medtronic or at least set up a royalties deal.
|
|
|
Post by seanismorris on Oct 14, 2014 12:50:27 GMT -5
Patent Question For some reason I'm unable to open the PDF but I noticed that this was filed in 2012. patents.justia.com/patent/20140302151Is is there anything different between the patents that are filed and published versions? I.e. Revisions made, etc. What does being published mean for the patent in general? Approval? Why the long delay before they are "published"?
|
|
|
Post by rockyp on Oct 14, 2014 13:38:46 GMT -5
There can be changes between the time of the original application and the time when the patent is published. It can continue to change until it is actually issued. You can use the US Patent & Trademark Office’s website to look at the history of a patent application through the Patent Application Information Retrieval system (PAIR). [http://portal.uspto.gov/pair/PublicPair]
For this application, publication 20140302151, the Image File Wrapper shows, for instance, that the claims have been revised by the applicant since the original submission.
|
|
|
Post by seanismorris on Oct 14, 2014 14:00:18 GMT -5
Interesting...thanks rockyp.
A lot of things are happening in the background with the patents that we would not necessarily know about.
For Example: claims 19-24 were added
19. The method of claim 17, wherein the peptide comprises: (D)Phe-(D)Phe-(D)Ile-(D)Arg-NH2 (SEQ ID NO: 1), (D)Phe-(D)Phe-(D)Nle-(D)Arg-NH2 (SEQ ID NO: 2), Trp-(D)Pro-Ser-Phe-NH2 (SEQ ID NO: 3), Trp-(D)Ser-Ser-Phe-NH2 (SEQ ID NO: 4), Dmt-D-Arg-Phe-Lys-NH2 (SEQ ID NO: 5), Ac-His-(D)Phe-Arg-(D)Trp-Gly-NH2 (SEQ ID NO: 6), or Ac-Nle-Gln-His-(D)Phe-Arg-(D)Trp-Gly-NH2 (SEQ ID NO:7). 20. The method of claim 17, wherein the peptide binds to a μ opioid receptor, a δ opioid receptor, or a κ opioid receptor, or combinations of receptors thereof, of cells in the central or peripheral nervous systems. 21. The inhalable analgesic composition of claim 12, wherein X is fumaryl, succinyl, glutaryl, maleyl, malonyl, oxalyl, or a pharmaceutically acceptable salt thereof. 22. The inhalable analgesic composition of claim 1, further comprising one or more pharmaceutical carrier or excipients selected from amino acids, sugars and surfactants. 23. The inhalable analgesic composition of claim 22, wherein the amino acids comprise at least one of leucine, isoleucine, glycine and methionine. 24. The inhalable analgesic composition of claim 22, wherein the sugars comprise at least one of mannitol, lactose, trehalose and raffinose.
|
|